NCT06339307Completed
A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients
A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for Lymph Node Metastasis in Gastric Cancer Patients
Source: ClinicalTrials.gov · Last updated 18 Sept 2025
Brief summary (registry, in English)
In our prior research, a risk scoring model for the occurrence of lymph node metastasis in patients who underwent radical gastrectomy for gastric cancer was established. To further validate this scoring model, a prospective study has been designed with the aim of prospectively assessing the model's clinical applicability.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 120 (actual)
- First submitted
- 17 Mar 2024
- Start date
- 15 Feb 2024
- Primary completion date
- 21 Apr 2024
- Lead sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06339307
What you commit to
- Study type: Observational
- Participants enrolled: 120
- From 15 Feb 2024 to the primary completion date, 21 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with a history of or concurrent other cancers;
- Post neoadjuvant radiotherapy or chemotherapy;
Other illness
- Patients with autoimmune diseases, inflammation, or hematological disorders;
- Active bleeding (as determined by endoscopic ultrasound and HGB ≤ 90);
Lab values
- Presence of active infection and inflammation (based on WBC count, patients with count of 10×10\^9 or higher should be evaluated through medical record examination for the presence of infection);
- History of blood transfusion, corticosteroid use, or leukocyte-stimulating medications within the past month prior to blood draw;
Other
- Incomplete clinical and pathological data.
Who the study is looking for
- Primary gastric adenocarcinoma;
- Curative surgery (with R0 resection, excluding palliative surgery and cases with distant metastasis).
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cancer Hospital of Tianjin Medical University Coordinator of this site? Confirm its status | Tianjin | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.